New preclinical evidence shows that oral arginine reduces toxic amyloid structures and eases behavioral impairments in Alzheimer’s models, highlighting a potential therapeutic path that now requires ...
Scientists unveil a novel supramolecular therapy that shields human neurons from amyloid-induced damage, offering new hope for treating Alzheimer’s and related neurodegenerative diseases. Study: ...
A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates found in Alzheimer’s disease, pointing towards a new potential therapeutic ...
After studying 140,000 versions of the Aβ42 peptide, scientists identified some of the earliest molecular interactions that drive the formation of harmful amyloid protein aggregates found in Alzheimer ...
In an unprecedented large-scale study, researchers have mapped out the first molecular events that cause harmful protein buildups in the brain of people with Alzheimer's disease. "By measuring the ...
Amino acid arginine has shown promise in reducing the buildup of amyloid-beta plaques in animal models of Alzheimer's disease. The corresponding study was published in Neurochemistry International and ...
ARIA is the most common side effect of anti–amyloid-beta MAB treatment. MABs increase vascular permeability, which can result in inflammation and leakage of proteinaceous fluid and blood products, ...
Hosted on MSN
Slow breathing during meditation reduces levels of Alzheimer’s-related proteins in the blood
A new study published in the journal Psychophysiology provides evidence that the specific way a person breathes during meditation may determine its impact on biological markers related to Alzheimer’s ...
Plaques all but vanish in response to some Aβ immunotherapies. Scientists suspect microglia orchestrate the mop-up, but don’t know how, exactly. Now, David Gate of Northwestern University in Chicago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results